大肠直肠癌的最新进展和挑战:从分子研究到治疗
Gao-Xiu Qi1, Rui-Xia Zhao1, Chen Gao1
1Department of Pathology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Medical Group), Qingdao 266042, Shandong Province, China.
World journal of gastroenterology
|June 20, 2025
概括
人工智能 (AI) 和器官技术通过个性化治疗和改善药物开发,为打击结直肠癌 (CRC) 提供了新的策略. 这些创新旨在克服CRC治疗中瘤异质性和耐药性等挑战.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 生物技术是生物技术.
背景情况:
- 大肠直肠癌 (CRC) 是全球癌症死亡率的主要原因之一.
- 基因组学和蛋白质组学的进步提高了对CRC分子机制的理解,使得有针对性和免疫疗法成为可能.
- 持续存在的挑战包括瘤异质性和耐药性,限制治疗的有效性.
研究的目的:
- 探索人工智能 (AI) 和器官技术的整合,以推进结直肠癌 (CRC) 研究和治疗.
- 突出AI在预测疾病风险,预后和治疗反应以及加速药物开发方面的潜力.
- 展示有机体作为个性化药物测试和治疗策略的平台.
主要方法:
- 利用人工智能分析复杂的遗传和临床数据,用于CRC的预测建模.
- 采用有机体模型,重述瘤特定的遗传和行为特征.
- 整合人工智能分析与基于器官的药物查以实现个性化医疗.
主要成果:
- 人工智能有助于更好地预测CRC风险,预后和治疗结果.
- 器官类药物为临床前药物评估和个性化治疗策略开发提供了一个可行的平台.
- 人工智能和有机体之间的协同作用有望加速CRC药物发现和量身定制患者护理.
结论:
- 人工智能和器官技术是克服结直肠癌治疗当前局限性的有希望的途径.
- 需要进一步的研究来解决人工智能数据质量,隐私和器官模型标准化方面的挑战.
- 未来的努力应专注于改进AI算法和器官系统,以提高CRC病原体的理解和治疗疗效.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.9K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.3K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:21Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K